Financials

  • Market Capitalization 89.28 M
  • Employee 6
  • Founded 2004
  • CEO Todd C. Brady M.D., Ph.D.
  • Website www.aldeyra.com
  • Headquarter Delaware, United States
  • FIGI BBG0029H8ZF6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.61
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3977
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.09 USD+1.46%-5.43%+37.50%+59.54%89.56 M USD
3979
ATRA
Atara Biotherapeutics, Inc. - Common Stock
8.90 USD-3.26%-7.00%+5.70%-39.66%89.34 M USD
3981
RLYB
Rallybio Corporation - Common Stock
16.79 USD-0.12%-0.12%+5.20%+3128.85%89.16 M USD
3984
ICCC
ImmuCell Corporation - Common Stock
9.79 USD-1.51%-0.81%-13.59%+55.64%88.91 M USD

Noticias